Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+70.8%
5Y CAGR+18.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+70.8%/yr
vs -11.6%/yr prior
5Y CAGR
+18.6%/yr
Recent acceleration
Acceleration
+82.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $179.97M | +66.5% |
| 2024 | $108.10M | +112.0% |
| 2023 | $51.00M | +41.2% |
| 2022 | $36.12M | +148.1% |
| 2021 | $14.56M | -81.0% |
| 2020 | $76.72M | -5.4% |
| 2019 | $81.13M | +37.3% |
| 2018 | $59.09M | +67.1% |
| 2017 | $35.35M | +281.7% |
| 2016 | $9.26M | - |